ERBB2 and breast cancer: Human epidermal growth factor receptor 2 (HER2), a well-acknowledged proto-oncogene involved in the genesis and progression of breast cancer, inhibits apoptosis, promotes proliferation, enhances the invasiveness of tumor cells, and facilitates angiogenesis and lymphangiogenesis of tumors.